US-based Schrodinger Inc on Thursday announced the opening of a dedicated research facility in Hyderabad in partnership with Sai Life Sciences
Published Date – Thu 20 Apr 23 08:42 PM
Source: Twitter/Minister of IT, Industry, MA and UD, Telangana.
Hyderabad: US-based Schrodinger Inc on Thursday announced the opening of a dedicated research facility in Hyderabad in partnership with Sai Life Sciences.
The joint venture, Sai Schrodinger Research Laboratories (SSRL), was officially inaugurated by Dr. Karen Akinsanya, President of Schrodinger Inc. Therapeutics R&D, at the company’s R&D campus, with members of the leadership team from Schrodinger and Sai Life Science in attendance.
“We selected Sai Life Sciences as our CRO late last year and we are very pleased that they are now ready to begin our project with an experienced and dedicated team in a state-of-the-art facility. Sai Life Sciences will be instrumental in advancing our drug discovery and early development activities, and we look forward to working closely together,” said Akinsanya.
In January 2023, Sai Life Sciences entered into a 5-year strategic agreement with Schrodinger, whose physics-based computing platform is transforming the discovery of treatments and materials, to establish SSRL in Hyderabad, India. Shortly thereafter, Sai Life Sciences began building the facility and recruiting scientific staff to drive the project to completion in an accelerated time frame, according to a release.
Sai Life Sciences CEO and Managing Director Krishna Kanumuri said the partnership with Schrodinger marks an exciting new beginning for Sai Life Sciences, with dedicated facilities to support multiple discovery projects.
Dr Karen Akinsanya and Krishna Kanumuri also met with IT and Industry Minister KT Rama Rao to discuss the nature of the collaboration and the role Sai Schrodinger Research Laboratories (SSRL) will play in advancing drug discovery and development.
“It is a pleasure to welcome Schrödinger of America to Hyderabad and congratulates its dedicated research facility (a world first) with @赛生活科学. This further reaffirms Telangana’s status as the intellectual capital of the world”: @KTRBRS pic.twitter.com/c0rmL0YgyE
— Minister of IT, Industry, MA and UD, Telangana (@MinisterKTR) April 20, 2023
Located within Sai Life Sciences’ R&D campus in Genome Valley, SSRL is a facility dedicated to integrating discovery workflows, including pharmaceutical and synthetic chemistry, in vitro biology and process chemistry. SSRL will access other Sai functions such as in vitro ADME and in vivo PK as needed. This relationship will support the advancement of programs utilizing Schrödinger’s verified computing platform.
Currently, SSRL has 75 full-time employees (FTEs) in medicinal chemistry, biology, process chemistry and analytical chemistry.
